Table 4.

Unadjusted and adjusted odds of mitral valve calcification (MVC) in each vascular bed in patients with rheumatoid arthritis and systemic lupus erythematosus.

	Carotid		Coronary		Ascending Aorta		Descending Aorta		Any Vascular Bed
	HR (95% CI)	p	HR (95% CI)	p	HR (95% CI)	p	HR (95% CI)	p	HR (95% CI)	p
Unadjusted	4.69 (1.38–15.90)	0.01	11.0 (3.60–33.86)	< 0.01	2.14 (0.71–6.47)	0.18	3.24 (1.19–8.82)	0.02	13.9 (1.75–105.80)	0.01
Age	4.54 (1.27–16.17)	0.17	4.54 (1.27–16.17)	0.02	2.58 (0.70–9.47)	0.15	1.54 (0.49–4.85)	0.48	8.12 (1.02–67.25)	0.04
Gender	3.94 (1.12–13.99)	0.03	10.31 (3.33–31.91)	< 0.01	2.09 (0.68–6.45)	0.20	3.31 (1.19–9.21)	0.02	16.00 (1.96–130.42)	0.01
BMI^*	2.10 (0.63–11.37)	0.17	4.50 (1.23–16.45)	0.02	2.74 (0.74–10.23)	0.13	1.62 (0.51–5.20)	0.42	10.0 (1.14–87.55)	0.04
Smoker^*	2.33 (0.54–10.02)	0.25	4.37 (1.21–15.89)	0.03	2.58 (0.68–9.75)	0.16	1.65 (0.51–5.33)	0.41	11.50 (1.22–108.56)	0.03
Hypertension^*	2.21 (0.51–9.58)	0.29	4.25 (1.17–15.42)	0.03	2.65 (0.70–10.03)	0.15	1.59 (0.50–5.09)	0.43	10.55 (1.20–93.02)	0.03
Diabetes^*	2.41 (0.56–10.47)	0.24	4.34 (1.19–15.81)	0.03	2.57 (0.69–9.57)	0.16	1.59 (0.50–5.07)	0.43	8.98 (1.04–97.15)	0.05
Hyperlipidemia^*	2.36 (0.53–10.58)	0.26	4.26 (1.17–15.42)	0.03	2.83 (0.75–10.64)	0.12	1.65 (0.51–5.30)	0.40	11.9 (1.29–110.10)	0.03
CRP^*	1.95 (0.39–9.76)	0.42	4.29 (0.94–19.53)	0.06	2.45 (0.55–10.96)	0.24	1.97 (0.44–8.45)	0.39	8.5 (1.07–82.45)	0.04
Duration of disease^*	1.87 (0.42–8.40)	0.41	3.88 (1.04–14.85)	0.04	4.15 (0.98–17.60)	0.06	1.65 (0.50–5.40)	0.41	9.00 (1.03–73.9)	0.04

↵* Adjusted hazard ratios together with age and gender. For abbreviations see Table 3.